Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience.

被引：1
|
作者：
Vera-Badillo, Francisco Emilio [1 ]
Leibowitz-Amit, Raya [1 ]
Templeton, Arnoud [1 ]
Seah, Jo-An [1 ]
Sridhar, Srikala S. [1 ]
Knox, Jennifer J. [1 ]
Tannock, Ian [1 ]
Joshua, Anthony Michael [1 ]
机构：
[1] Univ Toronto, Dept Med, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.159
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Low-dose abiraterone (abi) with food in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre experience.
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Seah, Jo-An
    Templeton, Arnoud J.
    Vera-Badillo, Francisco Emilio
    Alimohamed, Nimira S.
    Knox, Jennifer J.
    Sridhar, Srikala S.
    Tannock, Ian
    Joshua, Anthony M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
    Noonan, K. L.
    North, S.
    Bitting, R. L.
    Armstrong, A. J.
    Ellard, S. L.
    Chi, K. N.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (07) : 1802 - 1807
  • [3] 223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide
    Carles, J.
    Alonso, T.
    Mellado Gonzalez, B.
    Mendez Vidal, M. J.
    Vazquez Estevez, S.
    Gonzalez del Alba, A.
    Piulats, J. M.
    Borrega Garcia, P.
    Gallardo, E.
    Morales Barrera, R.
    Paredes, P.
    Reig, O.
    Garcias de Espana, C.
    Collado, R.
    Bonfill, T.
    Suarez, C.
    Malfettone, A.
    Garde, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S525 - S526
  • [4] Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
    Roberto Petrioli
    Edoardo Francini
    Letizia Laera
    Anna Ida Fiaschi
    Roberto Ponchietti
    Giandomenico Roviello
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 439 - 445
  • [5] Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
    Petrioli, Roberto
    Francini, Edoardo
    Laera, Letizia
    Fiaschi, Anna Ida
    Ponchietti, Roberto
    Roviello, Giandomenico
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 439 - 445
  • [6] Dose-modified abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre (PM) experience
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Seah, Jo-An
    Templeton, Arnoud J.
    Vera-Badillo, Francisco Emilio
    Solow, Henry L.
    Knox, Jennifer J.
    Sridhar, Srikala S.
    Tannock, Ian
    Joshua, Anthony Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [8] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [9] Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa Maria
    Bassi, Sunakshi
    Antonarakis, Emmanuel S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] Effects of abiraterone acetate and enzalutamide on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC)
    Ileana, Ecaterina
    Antoun, Sami
    Albiges, Laurence
    Massard, Christophe
    Di Palma, Mario
    Escudier, Bernard J.
    Fizazi, Karim
    Loriot, Yohann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345